Page 183 - 2019_08-Haematologica-web

ATRA protects impaired BM MSC in ITP
topoiesis. Crit Rev Oncol Hematol.
2007;64(2):83-89.
36. Cines DB, Bussel JB, Liebman HA, Luning
PE. The ITP syndrome: pathogenic and clin- ical diversity. Blood. 2009;113(26):6511- 6521.
37. Zhang F, Chu X, Wang L, et al. Cell-mediat- ed lysis of autologous platelets in chronic idiopathic thrombocytopenic purpura. Eur J Haematol. 2006;76(5):427-431.
38. LiJ,vanderWalDE,ZhuG,etal. Desialylation is a mechanism of Fc-indepen- dent platelet clearance and a therapeutic tar- get in immune thrombocytopenia. Nat Commun. 2015;6:7737.
39. Zhao C, Li X, Zhang F, Wang L, Peng J, Hou M. Increased cytotoxic T-lymphocyte-medi- ated cytotoxicity predominant in patients with idiopathic thrombocytopenic purpura without platelet autoantibodies. Haematologica. 2008;93(9):1428-1430.
40. Almeida-Porada G, Porada CD, Tran N, Zanjani ED. Cotransplantation of human stromal cell progenitors into preimmune fetal sheep results in early appearance of
human donor cells in circulation and boosts cell levels in bone marrow at later time points after transplantation. Blood. 2000;95 (11):3620-3627.
41. English K, Ryan JM, Tobin L, Murphy MJ, Barry FP, Mahon BP. Cell contact, prostaglandin E(2) and transforming growth factor beta 1 play non-redundant roles in human mesenchymal stem cell induction of CD4+CD25(High) forkhead box P3+ regula- tory T cells. Clin Exp Immunol. 2009;156(1):149-160.
42. Pérez-Simón JA, Tabera S, Sarasquete ME, et al. Mesenchymal stem cells are functionally abnormal in patients with immune throm- bocytopenic purpura. Cytotherapy. 2009;11(6):698-705.
43. Zhang D, Li H, Ma L, et al. The defective bone marrow-derived mesenchymal stem cells in patients with chronic immune thrombocytopenia. Autoimmunity. 2014;47 (8):519-529.
44. Martino MM, Maruyama K, Kuhn GA, et al. Inhibition of IL-1R1/MyD88 signalling pro- motes mesenchymal stem cell-driven tissue
regeneration. Nat Commun. 2016;7:11051. 45. de Mooij C, Netea MG, van der Velden W, Blijlevens N. Targeting the interleukin-1 pathway in patients with hematological dis-
orders. Blood. 2017;129(24):3155-3164.
46. Wynn RF, Hart CA, Corradi-Perini C, et al. A small proportion of mesenchymal stem cells strongly expresses functionally active CXCR4 receptor capable of promoting migration to bone marrow. Blood. 2004;104
(9):2643-2645.
47. Ding L, Morrison SJ. Haematopoietic stem
cells and early lymphoid progenitors occupy distinct bone marrow niches. Nature. 2013;495(7440):231-235.
48. Liu ZM, Wang KP, Ma J, Guo ZS. The role of all-trans retinoic acid in the biology of Foxp3+ regulatory T cells. Cell Mol Immunol. 2015;12(5):553-557.
49. Lu L, Lan Q, Li Z, et al. Critical role of all- trans retinoic acid in stabilizing human nat- ural regulatory T cells under inflammatory conditions. Proc Natl Acad Sci U S A. 2014;111(33): E3432-E3440.
haematologica | 2019; 104(8)
1675